Cellular & Molecular Biology for Orthopaedics
Overview: the cell & its organelles
The eukaryotic cell compartmentalises its work, and each compartment has an orthopaedic job. The nucleus stores DNA and is the site of transcription. The rough endoplasmic reticulum, studded with ribosomes, synthesises secreted and membrane proteins, while the smooth ER handles lipids and calcium, and the Golgi apparatus modifies, sorts and packages what the rough ER has made.
Mitochondria generate ATP and release the factors that trigger intrinsic apoptosis. Lysosomes degrade material with acid hydrolases.
How musculoskeletal cells are specialised. Chondrocytes and osteoblasts are matrix factories, so they carry prominent rough ER and Golgi to manufacture and secrete the collagen-rich extracellular matrix. The osteoclast works the other way: a multinucleated cell that resorbs bone using lysosomal enzymes and acid delivered at its ruffled border.
The mesenchymal stem cell. A cell-biology primer for orthopaedics needs the mesenchymal stem/stromal cell, the multipotent progenitor of the musculoskeletal lineages. It is drawn from bone marrow (the classic source), periosteum, adipose tissue, muscle and synovium.
Trilineage differentiation is its defining capacity: one progenitor can become osteoblast, chondrocyte or adipocyte, and also tenocyte or myocyte. Which line it takes is driven by a master transcription factor — Runx2, with Osterix/SP7, for the osteoblast, Sox9 for the chondrocyte and PPAR-gamma for the adipocyte. These are competing programmes running from one cell, and the osteoblast-versus-adipocyte switch matters in ageing and osteoporosis.
Identity. By the ISCT criteria an MSC is plastic-adherent and trilineage-capable, positive for the surface markers CD73, CD90 and CD105, and negative for the haematopoietic markers CD34 and CD45.
Why orthopaedics cares. Periosteal and marrow MSCs are the cellular engine of fracture healing, the osteogenic component of bone grafts, and the basis of cartilage and tendon repair and cell therapy — all developed on stem cells and MSCs in orthopaedics.
The cell cycle
A dividing cell runs through interphase — G1 for growth, S for DNA synthesis and replication, G2 for growth and preparation — and then M, mitosis. Cells that are not dividing rest in G0.
What drives it and what polices it. Progression is driven by cyclins and cyclin-dependent kinases (CDKs) and policed at checkpoints, principally G1/S and G2/M, which verify DNA integrity and replication before the cell commits. The tumour suppressors p53 — the guardian of the genome, which arrests the cycle or triggers apoptosis when DNA is damaged — and Rb are central to that policing.
Why it belongs in an orthopaedic syllabus. Loss of cell-cycle control, whether by oncogene activation or tumour-suppressor loss, is the basis of oncogenesis, and so of bone and soft-tissue tumours.
Concepts: the central dogma
Genetic information flows DNA → RNA → protein. In the nucleus a gene's DNA is transcribed by RNA polymerase into messenger RNA, which is processed — splicing, capping, a poly-A tail — and exported to the cytoplasm.
There, ribosomes translate the mRNA codons into a chain of amino acids, using transfer RNA. The polypeptide then folds and undergoes post-translational modification into a functional protein.
Where disease enters the flow. A mutation at any point yields an abnormal protein and disease, which is the molecular basis of many orthopaedic conditions: COL1A1/COL1A2 in osteogenesis imperfecta, FGFR3 in achondroplasia, COMP in pseudoachondroplasia and MED, and EXT1/2 in multiple hereditary exostoses.
The dogma gives the flow; these techniques interrogate each step, and each is examinable basic science.
- DNA: PCR amplifies a target sequence (qPCR quantifies, RT-PCR starts from RNA), the Southern blot detects a DNA sequence, and Sanger and next-generation sequencing (NGS) read the sequence — sarcoma gene panels, germline dysplasia testing.
- RNA: the Northern blot and RT-qPCR measure gene expression.
- Protein: the Western blot separates by size and detects with an antibody, ELISA quantifies a protein or antibody, and immunohistochemistry (IHC) localises a protein in a tissue section, which is how tumour markers are read. (Blot mnemonic: SNoW DRoP — Southern=DNA, Northern=RNA, Western=Protein.)
- Cytogenetics: the karyotype and FISH detect translocations and amplifications.
In orthopaedics these assays name the tumour. For example, EWSR1–FLI1 is found in Ewing sarcoma by RT-PCR or a FISH break-apart probe, SS18–SSX in synovial sarcoma, and MDM2 amplification in atypical lipomatous tumour and parosteal osteosarcoma by FISH. Immunohistochemistry supplies the markers (CD99 in Ewing, SATB2 for osteoblastic lesions), and broad-range 16S rRNA PCR detects the organism in culture-negative prosthetic joint infection. Both fusion-gene pages are worth reading beside this section, because they are where an abstract assay becomes the thing that names the tumour.
Collagen — the orthopaedic protein
Collagen is the dominant structural protein of the musculoskeletal system, and the best orthopaedic example of protein synthesis and post-translational modification. Five steps take it from gene to load-bearing fibril:
- Transcription and translation of pro-alpha chains on the rough ER, each carrying the repeating glycine-X-Y sequence (X often proline, Y often hydroxyproline).
- Hydroxylation of proline and lysine residues, which requires vitamin C as a cofactor.
- Glycosylation, and assembly of three chains into the triple helix, procollagen.
- Secretion, then cleavage of the propeptides to form tropocollagen.
- Fibril assembly and cross-linking by lysyl oxidase, a copper-dependent enzyme, which is what confers tensile strength.
Where scurvy sits. Scurvy is a failure at step two and at no other: the chains are made but cannot be stabilised, so what is secreted is under-hydroxylated and mechanically useless. That is why the disease presents as bleeding, poor healing and, in the child, a radiographically distinctive metaphysis.
The types. There are 28 collagen types. The fibrillar collagens (types I, II, III, V, XI and others) build the load-bearing frameworks. Type I predominates in bone, tendon and skin, type II in hyaline cartilage.
- Main location
- Bone, tendon, ligament, skin, annulus fibrosus
- Note
- Most abundant; defective in osteogenesis imperfecta
- Main location
- Hyaline (articular) cartilage, nucleus pulposus
- Note
- Cartilage; defective in some chondrodysplasias
- Main location
- Early wound/granulation tissue, vessels
- Note
- Laid down early in healing, later replaced by type I
- Main location
- Regulate fibril diameter (with I / II)
- Note
- Co-assemble with the major fibrillar collagens
- Main location
- Hypertrophic zone of the growth plate
- Note
- Marker of hypertrophic chondrocytes (endochondral ossification)
Clinical relevance: cell death & cell signalling
Apoptosis is active, ATP-dependent, regulated cell death: the cell shrinks, chromatin condenses, the membrane blebs, and the apoptotic bodies are cleared by phagocytes with no inflammation. Two pathways converge on caspases — the intrinsic, mitochondrial one, governed by the Bcl-2 family and cytochrome c release, and the extrinsic, death-receptor one such as Fas.
It is physiological at the growth plate, where hypertrophic chondrocytes undergo apoptosis during endochondral ossification, and pathological when dysregulated chondrocyte apoptosis contributes to osteoarthritis.
Necrosis is passive, unregulated death from injury or ischaemia: the cell swells, the membrane ruptures, the contents spill, and that spillage provokes inflammation. It is what is happening in infarction and in osteonecrosis — avascular necrosis of the hip is the clinical archetype — and in severe trauma and infection.
Cell signalling. Cells coordinate through chemical signals classified by the distance they travel: endocrine hormones through the bloodstream (PTH, oestrogen), paracrine diffusion to neighbours (growth factors in fracture healing), autocrine signalling back onto the cell that released it, and juxtacrine signalling by direct contact (Notch).
Each signal binds a receptor, at the cell surface or inside the cell, and triggers an intracellular cascade of second messengers, kinases and transcription factors that changes gene expression. That cascade is the machinery behind the bone-signalling pathways — Wnt, RANK–RANKL–OPG, BMP/TGF-beta, Hedgehog and Notch.
- Transcription is DNA to RNA, in the nucleus; translation is RNA to protein, at the ribosome. Do not swap them.
- Vitamin C serves the hydroxylation step and lysyl oxidase the cross-linking; they are different steps, and the vitamin C link is the favourite single-fact pull.
- Collagen types: I bone, tendon and skin, defective in osteogenesis imperfecta; II hyaline cartilage; III early healing; X hypertrophic physis.
- Apoptosis is not inflammatory. Necrosis is.
- p53 is the guardian of the genome, and its loss drives oncogenesis.
Viva practice
Exam viva
Practise clinical reasoning and management decisions out loud
“Walk me through the central dogma and use collagen to illustrate how a protein is made and modified. Why is vitamin C relevant?”
“Distinguish apoptosis from necrosis, and give orthopaedic examples of each. How do cells signal to one another?”
Exam cheat sheet
Organelles (ortho roles)
- Nucleus = DNA/transcription; rough ER + ribosomes = protein synthesis (collagen)
- Golgi = modify/package; mitochondria = ATP + intrinsic apoptosis
- Lysosomes = degradation (osteoclast bone resorption)
Cell cycle & central dogma
- G1 → S → G2 → M; checkpoints (G1/S, G2/M); cyclins/CDKs; p53 & Rb
- DNA → mRNA (transcription) → protein (translation)
- Mutations → disease: COL1A1 (OI), FGFR3 (achondroplasia), COMP (pseudoachondroplasia)
Collagen
- Gly-X-Y triple helix; prolyl/lysyl hydroxylation needs VITAMIN C (scurvy)
- Procollagen → secreted → cleaved → fibril → cross-linked (lysyl oxidase)
- Type I bone/tendon, II cartilage, III early healing, X hypertrophic physis
Cell death & signalling
- Apoptosis: programmed, ATP-dependent, caspases, NO inflammation (intrinsic + extrinsic)
- Necrosis: passive, swelling/lysis, inflammation (osteonecrosis, infarction)
- Signalling: endocrine / paracrine (fracture healing) / autocrine / juxtacrine
Evidence Base
Fibrillar collagens
- The fibrillar collagens (types I, II, III, V, XI, XXIV, XXVII) provide three-dimensional frameworks conferring mechanical strength; humans have 28 collagen types.
- The triple-helix structure depends on the amino-acid sequence (Gly-X-Y), hydrogen bonding and post-translational modifications such as prolyl 4-hydroxylation.
- Biosynthesis involves prolyl/lysyl hydroxylation, chaperones, trimerisation of procollagen, proteolytic maturation, fibril assembly and cross-linking.
Osteogenesis imperfecta
- Osteogenesis imperfecta is caused by dominant COL1A1/COL1A2 mutations in about 85% of individuals, affecting type I collagen quantity or structure - the central-dogma 'gene to protein to disease' exemplar.
- Many additional (mostly recessive) defects affect proteins of type I collagen synthesis, processing, secretion and post-translational modification, or bone-cell differentiation/activity.
- Phenotype extends beyond bone (cardiovascular, pulmonary, skin, hearing, dentinogenesis imperfecta); management is surgical + medical, with gene/cell and signalling therapies under study.
The role of apoptosis in the pathogenesis of osteoarthritis
- Apoptosis is an important physiological process for development and tissue homeostasis; dysregulated chondrocyte apoptosis contributes to osteoarthritis (cartilage degeneration).
- Inflammatory mediators (ROS, NO, IL-1beta, TNF-alpha, Fas) and signalling pathways (NF-kappaB, Wnt, Notch) drive chondrocyte apoptosis and matrix degradation.
- Connects core cell-death biology directly to a common orthopaedic disease and to potential therapeutic targets.
The collagen structure/biosynthesis facts come from Bella & Hulmes 2017 (DOI); the central-dogma-to-disease exemplar (COL1A1/COL1A2 in ~85% of osteogenesis imperfecta) from Marini et al. 2017 (DOI); and the apoptosis-in-OA links from Xiao et al. 2023 (DOI). The general cell-biology content (organelles, cell cycle, central dogma) is standard textbook science. The disease links are each developed on their own page, and this primer exists to make them make sense: osteogenesis imperfecta is the COL1A1/COL1A2 fault worked all the way through to brittle bone, achondroplasia the FGFR3 one, pseudoachondroplasia the COMP one, and multiple hereditary exostoses the EXT1/EXT2 one - all four sitting under skeletal dysplasias. The signalling cascades sketched above are set out in full in bone signalling pathways.